| 000 | 01130 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513131313.0 | ||
| 264 | 0 | _c19971212 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)64241-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFieschi, C | |
| 245 | 0 | 0 |
_aThrombolytic therapy for acute ischaemic stroke. ECASS Study Group. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 1997 |
||
| 300 |
_a1476; author reply 1477 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlasminogen Activators _xtherapeutic use |
| 650 | 0 | 4 |
_aStreptokinase _xtherapeutic use |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 700 | 1 | _aHacke, W | |
| 700 | 1 | _aKaste, M | |
| 700 | 1 | _aToni, D | |
| 700 | 1 | _aLesaffre, E | |
| 773 | 0 |
_tLancet (London, England) _gvol. 350 _gno. 9089 _gp. 1476; author reply 1477 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)64241-9 _zAvailable from publisher's website |
| 999 |
_c9341078 _d9341078 |
||